| Bioactivity | N-Myristoyl-Lys-Arg-Thr-Leu-Arg is a protein kinase C (PKC) inhibitor with an IC50 value of 75 μM. N-Myristoyl-Lys-Arg-Thr-Leu-Arg inhibits IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat[1]. |
| Invitro | N-Myristoyl-Lys-Arg-Thr-Leu-Arg (0-50 μM) inhibits the production and release of IL-2 from cultured Jurkat cells stimulated with TPA plus either PHA or OKT3 mAb[1]. |
| Name | N-Myristoyl-Lys-Arg-Thr-Leu-Arg |
| CAS | 125678-68-4 |
| Shortening | Myr-KRTLR |
| Formula | C42H82N12O8 |
| Molar Mass | 883.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg
CAS: 125678-68-4 F: C42H82N12O8 W: 883.18
N-Myristoyl-Lys-Arg-Thr-Leu-Arg is a protein kinase C (PKC) inhibitor with an IC50 value of 75 μM. N-Myristoyl-Lys-Arg-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.